OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing Cure
Anastasiya Kostyusheva, Dmitry Kostyushev, Sergey Brezgin, et al.
Genes (2018) Vol. 9, Iss. 10, pp. 483-483
Open Access | Times Cited: 16
Anastasiya Kostyusheva, Dmitry Kostyushev, Sergey Brezgin, et al.
Genes (2018) Vol. 9, Iss. 10, pp. 483-483
Open Access | Times Cited: 16
Showing 16 citing articles:
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification
Anastasiya Kostyusheva, Sergey Brezgin, Dieter Glebe, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 2264-2275
Open Access | Times Cited: 59
Anastasiya Kostyusheva, Sergey Brezgin, Dieter Glebe, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 2264-2275
Open Access | Times Cited: 59
Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus
Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 9, pp. 1779-1794
Open Access | Times Cited: 73
Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 9, pp. 1779-1794
Open Access | Times Cited: 73
A Global View to HBV Chronic Infection: Evolving Strategies for Diagnosis, Treatment and Prevention in Immunocompetent Individuals
Laura Ambra Nicolini, Andrea Orsi, Paola Tatarelli, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 18, pp. 3307-3307
Open Access | Times Cited: 39
Laura Ambra Nicolini, Andrea Orsi, Paola Tatarelli, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 18, pp. 3307-3307
Open Access | Times Cited: 39
Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus
Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 478-493
Open Access | Times Cited: 11
Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 478-493
Open Access | Times Cited: 11
Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss
Sylvia M. Brakenhoff, Robert A. de Man, André Boonstra, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 53, Iss. 2, pp. 314-320
Open Access | Times Cited: 23
Sylvia M. Brakenhoff, Robert A. de Man, André Boonstra, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 53, Iss. 2, pp. 314-320
Open Access | Times Cited: 23
Role of Biomarkers in Guiding Cure of Viral Hepatitis B
Marı́a Buti, Mar Riveiro‐Barciela, Francisco Rodríguez‐Frías, et al.
Seminars in Liver Disease (2019) Vol. 40, Iss. 01, pp. 049-060
Closed Access | Times Cited: 18
Marı́a Buti, Mar Riveiro‐Barciela, Francisco Rodríguez‐Frías, et al.
Seminars in Liver Disease (2019) Vol. 40, Iss. 01, pp. 049-060
Closed Access | Times Cited: 18
Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
Elia Moreno-Cubero, R.T. Sánchez del Arco, Julia Peña‐Asensio, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 17, pp. 1825-1838
Open Access | Times Cited: 16
Elia Moreno-Cubero, R.T. Sánchez del Arco, Julia Peña‐Asensio, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 17, pp. 1825-1838
Open Access | Times Cited: 16
Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
Xinhui Wang, Xiaoli Liu, Peng Wang, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1253-1267
Open Access | Times Cited: 10
Xinhui Wang, Xiaoli Liu, Peng Wang, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1253-1267
Open Access | Times Cited: 10
Clearing of Foreign Episomal DNA from Human Cells by CRISPRa-Mediated Activation of Cytidine Deaminases
Sergey Brezgin, Anastasiya Kostyusheva, N. I. Ponomareva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6865-6865
Open Access | Times Cited: 8
Sergey Brezgin, Anastasiya Kostyusheva, N. I. Ponomareva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6865-6865
Open Access | Times Cited: 8
Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
I‐Chin Wu, Wen‐Chun Liu, Yen‐Cheng Chiu, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1146-1146
Open Access | Times Cited: 7
I‐Chin Wu, Wen‐Chun Liu, Yen‐Cheng Chiu, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1146-1146
Open Access | Times Cited: 7
CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical Barriers
Dmitry Kostyushev, Anastasiya Kostyusheva, N. I. Ponomareva, et al.
Nucleic Acid Therapeutics (2021) Vol. 32, Iss. 1, pp. 14-28
Closed Access | Times Cited: 4
Dmitry Kostyushev, Anastasiya Kostyusheva, N. I. Ponomareva, et al.
Nucleic Acid Therapeutics (2021) Vol. 32, Iss. 1, pp. 14-28
Closed Access | Times Cited: 4
Newer Diagnostic Virological Markers for Hepatitis B Virus Infection
Reshu Agarwal, Ekta Gupta, Jasmine Samal, et al.
Euroasian Journal of Hepato-Gastroenterology (2024) Vol. 14, Iss. 2, pp. 214-220
Open Access
Reshu Agarwal, Ekta Gupta, Jasmine Samal, et al.
Euroasian Journal of Hepato-Gastroenterology (2024) Vol. 14, Iss. 2, pp. 214-220
Open Access
Genotypes Variation and Molecular Epidemiology Of The Hbv Chronic Liver Infection In The Local Population Of Pakistan: An Overview Of The Recent Literature
Bushra Tahreem, Ghadir Ali, Haroon Ahmad, et al.
Pakistan BioMedical Journal (2022)
Open Access | Times Cited: 1
Bushra Tahreem, Ghadir Ali, Haroon Ahmad, et al.
Pakistan BioMedical Journal (2022)
Open Access | Times Cited: 1
HBx Protein Potentiates Hepatitis B Virus Reactivation
Sergey Brezgin, Anastasiya Kostyusheva, N. I. Ponomareva, et al.
Molecular Biology (2022) Vol. 56, Iss. 5, pp. 713-722
Closed Access | Times Cited: 1
Sergey Brezgin, Anastasiya Kostyusheva, N. I. Ponomareva, et al.
Molecular Biology (2022) Vol. 56, Iss. 5, pp. 713-722
Closed Access | Times Cited: 1
Commentary: Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
Maria Pfefferkorn, Florian van Bömmel
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1
Maria Pfefferkorn, Florian van Bömmel
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1
HBV enfeksiyonunun tedavisinde CRISPR / Cas9 gen düzenleme sisteminin kullanımı
Medine Karadag Alpaslan
Gene Editing (2020) Vol. 1, Iss. 1, pp. 1-7
Open Access | Times Cited: 1
Medine Karadag Alpaslan
Gene Editing (2020) Vol. 1, Iss. 1, pp. 1-7
Open Access | Times Cited: 1
